Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology.

McMahon AD, Evans JM, McGilchrist MM, McDevitt DG, MacDonald TM.

Pharmacoepidemiol Drug Saf. 1998 Jul;7(4):275-80.

PMID:
15073990
2.

Simultaneous measurement of cardiac output and its distribution with microspheres in the rat.

McDevitt DG.

Cardiovasc Res. 2000 Jan 1;45(1):9-12. No abstract available.

PMID:
10728306
3.

Association of road-traffic accidents with benzodiazepine use.

Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM.

Lancet. 1998 Oct 24;352(9137):1331-6.

PMID:
9802269
4.

PACT data for dispensed drugs linked to NHS numbers are available now.

MacDonald TM, Parkinson J, Davey PG, Morris AD, McDevitt DG, McGilchrist MM.

BMJ. 1998 May 16;316(7143):1530. No abstract available.

5.

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.

MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG.

BMJ. 1997 Nov 22;315(7119):1333-7.

6.
7.

A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation.

McMahon AD, Evans JM, White G, Murray FE, McGilchrist MM, McDevitt DG, MacDonald TM.

J Clin Epidemiol. 1997 Mar;50(3):351-6.

PMID:
9120536
8.

Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland.

MacDonald TM, McMahon AD, Reid IC, Fenton GW, McDevitt DG.

BMJ. 1996 Oct 5;313(7061):860-1. No abstract available.

9.

An audit of the accuracy of upper gastrointestinal diagnoses in Scottish Morbidity Record 1 data in Tayside.

Dornan S, Murray FE, White G, McGilchrist MM, Evans JM, McDevitt DG, MacDonald TM.

Health Bull (Edinb). 1995 Sep;53(5):274-9.

PMID:
7490198
10.

A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.

Wheeldon NM, MacDonald TM, Prasad N, Maclean D, Peebles L, McDevitt DG.

QJM. 1995 Aug;88(8):565-70.

PMID:
7648243
11.

Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure.

Evans JM, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, McDevitt DG, MacDonald TM.

QJM. 1995 Aug;88(8):551-7.

PMID:
7648241
12.

Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study.

Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, MacDonald TM.

BMJ. 1995 Jul 1;311(6996):22-6.

14.

Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.

Lipworth BJ, Newnham DM, Clark RA, Dhillon DP, Winter JH, McDevitt DG.

Thorax. 1995 Jan;50(1):54-61.

15.

The utilisation and economic evaluation of antibiotics prescribed in primary care.

MacDonald TM, Collins D, McGilchrist MM, Stevens J, McKendrick AD, McDevitt DG, Davey PG.

J Antimicrob Chemother. 1995 Jan;35(1):191-204.

PMID:
7768769
16.

Effect of combined atenolol and nifedipine administration on psychomotor performance in normal subjects.

Gerrard L, Wheeldon NM, McDevitt DG.

Eur J Clin Pharmacol. 1995;48(3-4):229-33.

PMID:
7589046
17.

Central effects of the diuretic, bendrofluazide.

McDevitt DG, Currie D, Nicholson AN, Wright NA, Zetlein MB.

Br J Clin Pharmacol. 1994 Sep;38(3):249-56.

18.

The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade.

Wheeldon NM, McDevitt DG, Lipworth BJ.

Br J Clin Pharmacol. 1994 Aug;38(2):103-8.

19.

Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma.

Newnham DM, McDevitt DG, Lipworth BJ.

Am J Med. 1994 Jul;97(1):29-37.

PMID:
7913292
20.

Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle.

Wheeldon NM, Newnham DM, Coutie WJ, Peters JA, McDevitt DG, Lipworth BJ.

Br J Clin Pharmacol. 1994 Jun;37(6):583-8.

21.

Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.

Wheeldon NM, McDevitt DG, Lipworth BJ.

Br J Clin Pharmacol. 1994 Apr;37(4):363-9.

22.

Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.

Wheeldon NM, McDevitt DG, McFarlane LC, Lipworth BJ.

Clin Sci (Lond). 1994 Mar;86(3):331-7.

PMID:
7908864
23.

Central effects of repeated administration of atenolol and captopril in healthy volunteers.

McDevitt DG, Currie D, Nicholson AN, Wright NA, Zetlein MB.

Eur J Clin Pharmacol. 1994;46(1):23-8.

PMID:
8005182
24.

Extrapulmonary beta 2-responses to intravenous salbutamol during the menstrual cycle.

Newnham DM, Wheeldon NM, McFarlane LC, Clark GA, McDevitt DG, Lipworth BJ.

Eur J Clin Pharmacol. 1994;46(6):511-5.

PMID:
7995317
26.

Primary non-compliance with prescribed medication in primary care.

Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM.

BMJ. 1993 Oct 2;307(6908):846-8.

27.

Do beta 3-adrenoceptors mediate metabolic responses to isoprenaline.

Wheeldon NM, McDevitt DG, Lipworth BJ.

Q J Med. 1993 Sep;86(9):595-600.

PMID:
8255974
28.

The risks of symptomatic vaginal candidiasis after oral antibiotic therapy.

MacDonald TM, Beardon PH, McGilchrist MM, Duncan ID, McKendrick AD, McDevitt DG.

Q J Med. 1993 Jul;86(7):419-24.

PMID:
8210296
29.
30.

Investigation of putative cardiac beta 3-adrenoceptors in man.

Wheeldon NM, McDevitt DG, Lipworth BJ.

Q J Med. 1993 Apr;86(4):255-61.

PMID:
8392210
31.

Echocardiography in chronic heart failure in the community.

Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD.

Q J Med. 1993 Jan;86(1):17-23.

PMID:
8438044
32.

Central effects of combined bendrofluazide and atenolol administration. A single dose study in normal subjects.

Gerrard L, Wheeldon NM, McDevitt DG.

Eur J Clin Pharmacol. 1993;45(6):539-43.

PMID:
8157039
33.

Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.

Rahman AR, McDevitt DG, Struthers AD, Lipworth BJ.

Thorax. 1992 Dec;47(12):1056-9.

34.

Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.

Wheeldon NM, McDevitt DG, Lipworth BJ.

Br J Clin Pharmacol. 1992 Oct;34(4):337-43.

35.

General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions.

Keys J, Beardon PH, Lau C, Lang CC, McDevitt DG.

J R Soc Med. 1992 Aug;85(8):442-5.

36.

The effects of enalapril and spironolactone on terbutaline-induced hypokalemia.

Rahman AR, McDevitt DG, Struthers AD, Lipworth BJ.

Chest. 1992 Jul;102(1):91-5.

PMID:
1623802
37.

Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.

Wheeldon NM, McDevitt DG, Lipworth BJ.

Br J Clin Pharmacol. 1992 Apr;33(4):411-6.

38.

Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

Lipworth BJ, McDevitt DG.

Br J Clin Pharmacol. 1992 Feb;33(2):129-38. Review.

39.
40.

Central effects of the calcium antagonist, nifedipine.

McDevitt DG, Currie D, Nicholson AN, Wright NA, Zetlein MB.

Br J Clin Pharmacol. 1991 Nov;32(5):541-9.

41.

Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.

McMurray J, Lang CC, MacLean D, Struthers AD, McDevitt DG.

Int J Cardiol. 1991 Jun;31(3):295-303.

PMID:
1679047
42.

Measurement of normal human airways response to beta-adrenoceptor stimulation using a forced oscillation technique.

Lipworth BJ, Clark RA, McDevitt DG.

J Clin Pharm Ther. 1991 Jun;16(3):187-91.

PMID:
1678392
43.

The effect of pindolol on creatine kinase is not due to beta 2-adrenoceptor partial agonist activity.

Wheeldon NM, Newnham DM, Fraser GC, McDevitt DG, Lipworth BJ.

Br J Clin Pharmacol. 1991 Jun;31(6):723-4. No abstract available.

44.
45.
46.
47.

Clinical audit of theophylline use in general practice.

Neville RG, McDevitt DG.

Br J Clin Pract. 1991 Spring;45(1):18-20.

PMID:
1931533
48.

A double-blind placebo-controlled trial of theophylline in general practice.

Neville RG, Crombie IK, McDevitt DG.

Br J Clin Pract. 1991 Spring;45(1):14-7.

PMID:
1931532
49.

A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.

Lipworth BJ, Irvine NA, McDevitt DG.

Eur J Clin Pharmacol. 1991;40(2):135-9.

PMID:
1676675
50.

The effects of chronic dosing on the beta 1 and beta 2-adrenoceptor antagonism of betaxolol and atenolol.

Lipworth BJ, Irvine NA, McDevitt DG.

Eur J Clin Pharmacol. 1991;40(5):467-71.

PMID:
1653143

Supplemental Content

Loading ...
Support Center